Vir Biotechnology Inc.

11/15/2024 | Press release | Distributed by Public on 11/15/2024 10:02

Vir Biotechnology Announces Positive End of Treatment Results for Tobevibart and Elebsiran Combinations in Chronic Hepatitis B from the MARCH Study at AASLD The Liver Meeting